Information  X 
Enter a valid email address

Renewi PLC (RWI)

  Print      Mail a friend       Annual reports

Wednesday 05 February, 2020

Renewi PLC

Director/PDMR Shareholding

RNS Number : 9695B
Renewi PLC
05 February 2020
 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Otto de Bont

2

 

Reason for the notification

 

a)

 

Position/status

 

CEO

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Renewi plc

b)

 

LEI

 

213800CNEIDZBL17KU22

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 10 pence each

 

 

GB007995243

 

 

b)

 

Nature of the transaction

 

 

Market Purchase

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

€0.4358

 

20,000

 

€0.4447

30,000

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

50,000

 

20,000 shares at  €0.4358 per share

 

30,000 shares at  €0.4447 per share

 

e)

 

Date of the transaction

 

 

20,000 shares on 3 February 2020

 

30,000 shares on 4 February 2020

 

f)

 

Place of the transaction

 

 

Euronext Amsterdam

 

Contact

Philip Griffin-Smith

Renewi plc Group Company Secretary +44(0)1908 650586

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected]seg.com or visit www.rns.com.
 
END
 
 
DSHBRGDDRXGDGGS

a d v e r t i s e m e n t